home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Medical Devices: EU Directives, Guidance Documents, CE Marking Process and ISO Certification Programs

 
  June 27, 2012  
     
 
ComplianceOnline, Online Event
2012-06-29


Why Should You Attend:

This webinar is focused on understanding the requirements of the Medical Device Directives, their linkage to the EU Clinical Trial Directive and the requirements of CE Marking and ISO Certification on commercializing products. The course covers all relevant topics in brief associated with the Directives and Guidance Documents, the reasons behind their introduction and a review of methods for effective implementation.

Key Topics to be Discussed:

  • The current regulatory situation in relation to Medical Devices in the EU.
  • The purpose of the Medical Device Directives.
  • Meeting the New Requirements for Conformity Assessment by Product Type.
  • 2010 Directive Changes; Additional Requirements.
  • Understanding the impact the Directive will have on developing and marketing new Medical Device products.
  • An overview of key areas of the Directive:
    • Scope of application and definition
    • Essential Requirements
    • Medical Device Type & Process Path
    • Medical Device Technical File
    • Clinical Investigations
    • Clinical Evaluations
    • Notified Bodies
  • Gain a detailed understanding of all Guidance Documents available to assist in the implementation of these directives.
 
 
Organized by: Complianceonline
Invited Speakers:

Robert J. Russell , (Bob) is the President of RJR Consulting, Inc. RJR Consulting Inc. specializes in understanding global regulatory issues for the pharmaceutical industry. Bob has more than 25 years of experience working with FDA and the Commission on technical issues as they relate to policy development, regulation, clinical trial and the medical device development process.

Prior to entering the consulting field, Mr. Russell was the Global Director of Regulatory Affairs for two Fortune 100 firms. These companies were major raw material suppliers to the pharmaceutical and medical device industry and one a joint-venture parent of a major pharmaceutical division.

 
Deadline for Abstracts: 2012-06-28
 
Registration:

For Registration:

http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=701369?channel=hummolgen

E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.